Citation: | ZHU Yiyi, YU Ruiqi, YUAN Tao, ZHANG Huabing, WANG Xi, WANG Linjie, WU Xueyan. Hyperandrogenism in postmenopausal women: a case report and literature review[J]. Chinese Journal of General Practice, 2023, 21(8): 1444-1448. doi: 10.16766/j.cnki.issn.1674-4152.003142 |
[1] |
CUSSEN L, MCDONNELL T, BENNETT G, et al. Approach to androgen excess in women: clinical and biochemical insights[J]. Clin Endocrinol (Oxf), 2022, 97(2): 174-186. doi: 10.1111/cen.14710
|
[2] |
SHIFREN J L, DAVIS S R. Androgens in postmenopausal women: a review[J]. Menopause, 2017, 24(8): 970-979. doi: 10.1097/GME.0000000000000903
|
[3] |
STANCZYK F Z, CHAIKITTISILPA S, SRIPRASERT I, et al. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women[J]. Climacteric, 2019, 22(2): 169-174. doi: 10.1080/13697137.2018.1535584
|
[4] |
KANAKIS G A, TSAMETIS C P, GOULIS D G. Measuring testosterone in women and men [J]. Maturitas, 2019, 125: 41-44. doi: 10.1016/j.maturitas.2019.04.203
|
[5] |
SHARMA A, KAPOOR E, SINGH R J, et al. Diagnostic thresholds for androgen-producing tumors or pathologic hyperandrogenism in women by use of total testosterone concentrations measured by liquid chromatography-tandem mass spectrometry[J]. Clin Chem, 2018, 64(11): 1636-1645. doi: 10.1373/clinchem.2018.290825
|
[6] |
ELHASSAN Y S, IDKOWIAK J, SMITH K, et al. Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women[J]. J Clin Endocrinol Metab, 2018, 103(3): 1214-1223. doi: 10.1210/jc.2017-02426
|
[7] |
戴好, 卢琳, 邢小平, 等. 中剂量地塞米松雄激素抑制试验在女性高雄激素血症中的诊断价值[J]. 中华医学杂志, 2018, 98(26): 2073-2077. doi: 10.3760/cma.j.issn.0376-2491.2018.26.003
DAI H, LU L, XING X P, et al. Efficacy of medium dose dexamethasone androgen suppression test in the diagnosis of female hyperandrogenism[J]. National Medical Journal of China, 2018, 98(26): 2073-2077. doi: 10.3760/cma.j.issn.0376-2491.2018.26.003
|
[8] |
ZOU M, CHEN R, WANG Y H, et al. Clinical and ultrasound characteristics of virilizing ovarian tumors in pre- and postmenopausal patients: a single tertiary center experience[J]. Orphanet J Rare Dis, 2021, 16(1): 426. doi: 10.1186/s13023-021-02057-z
|
[9] |
HICKMAN L C, GOODMAN L, FALCONE T. Value of selective venous catheterization in the diagnosis of hyperandrogenism[J]. Fertil Steril, 2017, 108(6): 1085. doi: 10.1016/j.fertnstert.2017.08.037
|
[10] |
MAMOOJEE Y, GANGURI M, TAYLOR N, et al. Clinical case seminar: postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis [J]. Clin Endocrinol (Oxf), 2018, 88(1): 13-20. doi: 10.1111/cen.13492
|
[11] |
BAHAELDEIN E, BRASSILL M J. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women[J]. Endocrinol Diabetes Metab Case Rep, 2018, 2018: 18-0084. DOI: 10.1530/EDM-18-0084.
|
[12] |
HIRSCHBERG A L. Approach to investigation of hyperandrogenism in a postmenopausal woman[J]. J Clin Endocrinol Metab, 2022: dgac673. DOI: 10.1210/clinem/dgac673.
|
[13] |
王曦, 许建萍, 刘兆祥, 等. GnRH类似物治疗绝经后促性腺激素依赖性高雄激素血症持续缓解一例并文献复习[J]. 中华内分泌代谢杂志, 2018, 34(1): 53-56.
WANG X, XU J P, LIU Z X, et al. Effective GnRH analogue treatment and persistent remission of postmenopausal gonadotropin dependent hyperandrogenism: one case report and literature review[J]. Chinese Journal of Endocrinology and Metabolism, 2018, 34(1): 53-56.
|
[14] |
万惠卿, 蔡玉群, 李薇, 等. 女性血清睾酮水平及年龄与代谢综合征的关系[J]. 中华全科医学, 2016, 14(2): 251-253. doi: 10.16766/j.cnki.issn.1674-4152.2016.02.030
WAN H Q, CAI Y Q, LI W, et al. Correlation between serum testosterone and age with metabolic syndrome in women[J]. Chinese Journal of General Practice, 2016, 14(2): 251-253. doi: 10.16766/j.cnki.issn.1674-4152.2016.02.030
|
[15] |
ZAMAN A, ROTHMAN M S. Postmenopausal hyperandrogenism: evaluation and treatment strategies[J]. Endocrinol Metab Clin North Am, 2022, 50(1): 97-111.
|